Tujuan: Mengumpulkan informasi mengenai penanganan dan komplikasi diabetes, serta kesadaran pengendalian diri sendiri penderita diabetes di Indonesia. Studi ini juga mengevaluasi perspektif dokter, aspek psikologis, dan kualitas hidup pasien. Metode: Studi non-intervensi, potong lintang, merekrut 1832 pasien dari pusat kesehatan sekunder dan tersier di Indonesia. Data mengenai demografi , riwayat medis, faktor resiko, dan laporan pemeriksaan klinis termasuk laboratorium dikumpulkan dari rekam medis pasien. Sampel darah dikumpulkan untuk pengukuran HbA1c yang tersentralisasi.

Aims/IntroductionTo estimate the prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians based on the National Basic Health Research 2007.Materials and MethodsThe statistical analyses of a cross‐sectional survey included the data of 15,332 adults, aged 18–55 years, living in an urban area. Blood glucose was measured by an automatic clinical chemistry analyzer by 2‐h, 75‐g post glucose load after an overnight fast. Weight, height, waist circumference and blood pressure data were measured and recorded, whereas the sociodemographic and prior illness data were collected by interviewing the participants.ResultsThe prevalence of diabetes mellitus in productive age urban Indonesians was 4.6%, consisting of 1.1% previously diagnosed diabetes mellitus and 3.5% undiagnosed diabetes mellitus. Diabetes mellitus affected more women than men, which increased with age, was higher among the high socioeconomic group and increased with increasing body mass index. The prevalence of diabetes mellitus was higher in centrally obese people. Hypertension was highly related with diabetes mellitus occurrence. The prevalence of previously diagnosed diabetes mellitus with overweight or obese was 68.4%, with central obesity 41.7%, with hypertension 41.4% and with dyslipidemia more than 50%. The prevalence of undiagnosed diabetes respondents with overweight or obese was 68,7%, with central obesity 43.8%, with hypertension 49.4% and with dyslipidemia more than 50%.ConclusionsThese results show that comprehensive strategies for the prevention and control of the problem of diabetes are urgently required.

Summary Obesity is a chronic disease in which the abnormal or excessive accumulation of body fat leads to impaired health and increased risk of mortality and chronic health complications. Prevalence of obesity is rising rapidly in South and Southeast Asia, with potentially serious consequences for local economies, healthcare systems, and quality of life. Our group of obesity specialists from Bangladesh, Brunei Darussalam, India, Indonesia, Malaysia, Philippines, Singapore, Sri Lanka, Thailand, and Viet Nam undertook to develop consensus recommendations for management and care of adults and children with obesity in South and Southeast Asia. To this end, we identified and researched 12 clinical questions related to obesity. These questions address the optimal approaches for identifying and staging obesity, treatment (lifestyle, behavioral, pharmacologic, and surgical options) and maintenance of reduced weight, as well as issues related to weight stigma and patient engagement in the clinical setting. We achieved consensus on 42 clinical recommendations that address these questions. An algorithm describing obesity care is presented, keyed to the various consensus recommendations.

A study on the prevalence of coronary heart disease (CHD) and its risk factors in Ceningan Island was conducted. The prevalence of CHD was 11.5%. Older age (odds ratio, OR, 27.0), underweight (OR, 3.6), systolic hypertension (OR, 4.6), high total cholesterol (OR, 5.9), and high low-density lipoprotein cholesterol (OR, 3.1) were risk factors for a history of myocardial infarction (MI). By logistic regression analysis, only age (B=3.937) and underweight (B=1.275) consistently appeared to be risk factors for MI. The prevalence of CHD in the population was comparatively high.

This study is from the Acarbose pooled Database Integrated Analysis-NonInterventional Studies (AcarDIA-NIS) project. AbstractBackground Alpha-glucosidase inhibitors are recommended in some international guidelines as first-line, second-line and third-line treatment options but are not used worldwide due to perceived greater effectiveness in Asians than Caucasians.